ZA9811338B - Process for the production of fludarabine-phosphate lithium sodium potassium calcium and magnesium salts - Google Patents

Process for the production of fludarabine-phosphate lithium sodium potassium calcium and magnesium salts

Info

Publication number
ZA9811338B
ZA9811338B ZA9811338A ZA9811338A ZA9811338B ZA 9811338 B ZA9811338 B ZA 9811338B ZA 9811338 A ZA9811338 A ZA 9811338A ZA 9811338 A ZA9811338 A ZA 9811338A ZA 9811338 B ZA9811338 B ZA 9811338B
Authority
ZA
South Africa
Prior art keywords
fludarabine
production
magnesium salts
sodium potassium
phosphate lithium
Prior art date
Application number
ZA9811338A
Other languages
English (en)
Inventor
Ulf Tilstam
Thomas Schmitz
Klaus Nickisch
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7852365&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA9811338(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of ZA9811338B publication Critical patent/ZA9811338B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/19—Purine radicals with arabinosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9811338A 1997-12-11 1998-12-10 Process for the production of fludarabine-phosphate lithium sodium potassium calcium and magnesium salts ZA9811338B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19756289 1997-12-11

Publications (1)

Publication Number Publication Date
ZA9811338B true ZA9811338B (en) 1999-06-10

Family

ID=7852365

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9811338A ZA9811338B (en) 1997-12-11 1998-12-10 Process for the production of fludarabine-phosphate lithium sodium potassium calcium and magnesium salts

Country Status (20)

Country Link
US (2) US6046322A (cs)
EP (1) EP1047704B2 (cs)
JP (2) JP4261051B2 (cs)
KR (2) KR20050085937A (cs)
AT (2) ATE231880T1 (cs)
AU (1) AU739574B2 (cs)
CA (1) CA2313486A1 (cs)
CZ (1) CZ296366B6 (cs)
DE (2) DE59807096D1 (cs)
DK (1) DK1047704T4 (cs)
ES (1) ES2190136T5 (cs)
HU (1) HU226997B1 (cs)
IL (1) IL136283A (cs)
NO (1) NO315324B1 (cs)
PL (1) PL195712B1 (cs)
SI (1) SI1047704T2 (cs)
SK (1) SK283475B6 (cs)
TW (1) TW424093B (cs)
WO (1) WO1999029710A2 (cs)
ZA (1) ZA9811338B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4261051B2 (ja) 1997-12-11 2009-04-30 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト リン酸フルダラビンのリチウム、ナトリウム、カリウム、カルシウム及びマグネシウム塩の製造方法、リン酸フルダラビンを製造するための精製方法及び少なくとも９９．５％の純度を有するリン酸フルダラビン
KR100381930B1 (ko) * 2000-03-16 2003-04-26 (주)바이오니아 유전자 변형 농산물 검출방법 및 검출용 프라이머
EP1453536A4 (en) 2001-12-12 2009-08-26 Mayne Pharma Int Pty Ltd COMPOSITION FOR PRESERVING VIRUSES
DE10164510A1 (de) * 2001-12-20 2003-07-10 Schering Ag Orale Fludara reinst Formulierung mit schneller Freisetzung des Wirkstoffes
CA2487070A1 (en) * 2002-05-24 2003-12-04 Sicor Inc. Aqueous fludarabine phosphate composition
EP1464708A1 (en) * 2003-04-03 2004-10-06 Pro. Bio. Sint. S.p.A. A process for the preparation of fludarabine phosphate from 2-fluoroadenine
US7698201B2 (en) * 2006-09-14 2010-04-13 The Prudential Insurance Company Of America Financial instrument utilizing an optional benefit election
CN103040855B (zh) * 2012-12-28 2014-05-14 海南锦瑞制药股份有限公司 一种磷酸氟达拉滨的药物组合物及其制备方法
EP3342778B1 (en) * 2015-08-28 2022-01-12 Zhejiang Hisun Pharmaceutical Co., Ltd. Crystal form of fludarabine phosphat, preparation method therefor, and application thereof
CN109265505A (zh) * 2018-09-12 2019-01-25 连云港杰瑞药业有限公司 一种磷酸氟达拉滨异构体杂质的合成方法
WO2025038371A1 (en) * 2023-08-11 2025-02-20 Purdue Research Foundation Salt-loaded solid lipid nanoparticles loaded with an active agent

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE756704A (fr) * 1969-09-26 1971-03-01 Parke Davis & Co Procede de production du 5'-phosphate de 9-(beta-d- arabinofuranosyl) adenine et de ses sels
US4210745A (en) * 1978-01-04 1980-07-01 The United States Of America As Represented By The Department Of Health, Education And Welfare Procedure for the preparation of 9-β-D-arabinofuranosyl-2-fluoroadenine
US4188378A (en) * 1978-01-04 1980-02-12 The United States Of America As Represented By The Department Of Health, Education And Welfare Anticancer and antiviral activity of 9-β-D-arabinofuranosyl-2-fluoroadenine
US4357324A (en) * 1981-02-24 1982-11-02 The United States Of America As Represented By The Department Of Health And Human Services Prodrug derivatives of 9β-D-arabinofuranosyl-2-fluoroadenine
DE3323621A1 (de) 1982-07-08 1984-03-01 Yamasa Shoyu K.K., Choshi, Chiba Pharmazeutisches praeparat mit die antitumor-wirkung verstaerkender wirkung, ein solches praeparat enthaltende chemotherapeutische zusammensetzung und verwendung des praeparates zur unterstuetzung der antitumor-behandlung beim menschen und tier
US5110919A (en) * 1989-12-04 1992-05-05 Ash Stevens, Inc. Process for the preparation of 2-amino-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl) adenine and novel intermediates
AU633755B2 (en) * 1990-06-27 1993-02-04 Ash Stevens, Inc. Process for the preparation of 9-beta-d-arabinofuranosyl-2-fluoroadenine 5'-phosphate
US5602246A (en) 1992-11-25 1997-02-11 Schering Aktiengesellschaft Process for the preparation of fludarabine or fludarabine phosphate from guanosine
FR2701027B1 (fr) * 1993-02-01 1997-07-18 Warner Lambert Co Procede de synthese ameliore du 9-(beta-d-arabinofuranosyl)adenine 5'-phosphate.
DE19543052A1 (de) * 1995-11-06 1997-05-07 Schering Ag Verfahren zur Herstellung und Reinigung von Fludarabin-Phosphat und die Verwendung von sauren Ionenaustauschern im Verfahren
IT1276126B1 (it) 1995-11-14 1997-10-27 Archimica Spa Procedimento per la preparazine di 9-((2-idrossietossi)metil) guanina
JP4261051B2 (ja) 1997-12-11 2009-04-30 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト リン酸フルダラビンのリチウム、ナトリウム、カリウム、カルシウム及びマグネシウム塩の製造方法、リン酸フルダラビンを製造するための精製方法及び少なくとも９９．５％の純度を有するリン酸フルダラビン
US6174873B1 (en) 1998-11-04 2001-01-16 Supergen, Inc. Oral administration of adenosine analogs

Also Published As

Publication number Publication date
JP2009040797A (ja) 2009-02-26
KR100532898B1 (ko) 2005-12-05
WO1999029710A3 (de) 1999-09-10
DE29825173U1 (de) 2005-12-22
US7547776B1 (en) 2009-06-16
EP1047704B1 (de) 2003-01-29
KR20050085937A (ko) 2005-08-29
HU226997B1 (en) 2010-04-28
DK1047704T4 (da) 2008-03-25
HUP0100169A3 (en) 2002-04-29
NO20002962L (no) 2000-06-09
SK8872000A3 (en) 2001-03-12
IL136283A (en) 2006-10-31
EP1047704B2 (de) 2007-11-07
TW424093B (en) 2001-03-01
AU2155099A (en) 1999-06-28
AU739574B2 (en) 2001-10-18
AT8617U1 (de) 2006-10-15
DK1047704T3 (da) 2003-06-23
US6046322A (en) 2000-04-04
ES2190136T3 (es) 2003-07-16
SK283475B6 (sk) 2003-08-05
NO20002962D0 (no) 2000-06-09
IL136283A0 (en) 2001-05-20
ATE231880T1 (de) 2003-02-15
CA2313486A1 (en) 1999-06-17
PL195712B1 (pl) 2007-10-31
HK1033831A1 (en) 2001-09-28
KR20010032919A (ko) 2001-04-25
WO1999029710A2 (de) 1999-06-17
DE59807096D1 (de) 2003-03-06
PL341659A1 (en) 2001-04-23
HUP0100169A1 (hu) 2001-11-28
CZ20002159A3 (cs) 2000-09-13
JP2001525418A (ja) 2001-12-11
ES2190136T5 (es) 2008-03-01
CZ296366B6 (cs) 2006-02-15
JP4261051B2 (ja) 2009-04-30
SI1047704T1 (en) 2004-02-29
NO315324B1 (no) 2003-08-18
EP1047704A2 (de) 2000-11-02
SI1047704T2 (sl) 2008-02-29

Similar Documents

Publication Publication Date Title
AU1677999A (en) Process for the preparation of magnesium and carbonate substituted hydroxyapatite
IL113732A0 (en) A process for the production of anhydrous magnesium chloride
CZ151599A3 (cs) Způsob krystalizace draselné soli losartanu
ZA9811338B (en) Process for the production of fludarabine-phosphate lithium sodium potassium calcium and magnesium salts
SG65049A1 (en) Process for the production of polyther polyols
AU5584699A (en) Process for producing potassium sulfate from potash and sodium sulfate
IL133363A (en) Process for the production of herapin
HRP970181A2 (en) Continuous process for the production of precipitated calcium carbonate
GB9802999D0 (en) Production of products containing precipitated calcium carbonate
AU4389096A (en) Production of cefotaxime and new sodium salts
AU5329399A (en) Methods of purifying lithium salts
SG44950A1 (en) Continuous process for the manufacture of sodium C4C8alkoxide
GB2291414B (en) Process for the manufacture of anhydrous sodium carbonate
IL113104A0 (en) Process for the production of granulated potassium chloride
AU3463095A (en) Process to produce aminocarboxylic acids containing low residual salt
AU1416295A (en) Production of crystalline sodium disilicates
EP0700900A4 (en) PROCESS FOR PRODUCING ACYLOXYBENZENESULFONIC ACID OR ITS SALT
FI973836A0 (fi) Enfasig gipsbaeddsprocess foer produktion av kaliumsalter
IL136026A0 (en) Process for the production of formylimidazoles
ZA984269B (en) Process for the manufacture of sodium percarbonate
GB2323971B (en) Process for the production of polarisation selective reflectors
IL121638A0 (en) Method of production of magnesium
ZA9810169B (en) Process for preparing calcium carbonate
SI0716640T1 (en) Process for producing granulated sodium percarbonate
HUP0100026A3 (en) Process for the preparation of aminophosphonic acids